In Public-Private Deal, New York State Invests $225 Million and Athenex Invests $1.62 Billion to Create 1,400 Jobs
Tough Market and Clinical Failures Beat Up Two Massachusetts Biotechs
Like Dimension Therapeutics, More Than Half of Yumanity's Employees are Women
Gene Therapy Company Bamboo Therapeutics Raises $49.5 Million in Apparent Series A Financing Round
GlaxoSmithKline (GSK) Slapped with a $53 Million Fine for Paying Off Competitors
Investors Aren't Impressed as Charlie Sheen Reveals He Wants in on Tiny CytoDyn (CYDY)'s HIV Drug Trial
Why Sanofi Genzyme (SNY) is Still Defying the Odds Five Years After Being Acquired
Google (GOOG)'s VC Firm GV Sits on a $2.4 Billion Cash Pile, Seeks to be a Big Player in Biotech and Healthcare
Valeant (VRX) Uses Rare Accounting Move to Hide the True Details of Complex Deals
Apellis Pharma Bags $47 Million Series D Financing
Grail CEO Jeff Huber Driven By Personal Tragedy to Develop Early Cancer Screening Technology
Pfizer (PFE)'s $200 Million Massachusetts Expansion Could Create Hundreds of New Jobs
Top Four California Life Science Job Regions
Theranos in Jeopardy of Losing Biggest Blood-Testing Client
Incyte (INCY) Stock Tumbles After Halting Another Jakafi Trial for Treating Solid Tumors
Facing Tough Competition from Regeneron (REGN) and Amgen (AMGN), Aegerion (AEGR) Slashes 25% of Workforce
AstraZeneca PLC (AZN) Rumored to Be Interested in Buying Intercept Pharma (ICPT)
Investors And Scientists Question Whether Brent Saunders Will "Get Religion" And Support Pfizer (PFE)'s Internal R&D
See All News >
See All News >
Pfizer (PFE)'s $200 Million Massachusetts Expansion Could Create Hundreds of New Jobs
Top Four California Life Science Job Regions
Theranos in Jeopardy of Losing Biggest Blood-Testing Client
Incyte (INCY) Stock Tumbles After Halting Another Jakafi Trial for Treating Solid Tumors
Facing Tough Competition from Regeneron (REGN) and Amgen (AMGN), Aegerion (AEGR) Slashes 25% of Workforce
AstraZeneca PLC (AZN) Rumored to Be Interested in Buying Intercept Pharma (ICPT)
Investors And Scientists Question Whether Brent Saunders Will "Get Religion" And Support Pfizer (PFE)'s Internal R&D
This Chart Shows Who Marries CEOs, Doctors, Chefs And Janitors
MEDA Snaps Up Swedish Drugmaker Meda AB (MEDA-A.ST) in $7.2 Billion Deal
Former Google (GOOG) Exec to Take Helm at San Francisco Diagnostic Firm Grail
Armed with $50 Million from Google (GOOG), Celgene (CELG) and More, ARMO BioSciences Eyes Next-Gen Cancer Drug Combos
Chugai Pharma's Alecensa Trial Stopped Early After Successfully Meeting Primary Endpoint
Three Biotech Stocks to Buy When the Market Crashes
Ex-FDA Head Accused of Conspiring to Suppress Information About Harmful Effects of Johnson & Johnson (JNJ) Antibiotic
Patient Deaths Push the FDA to Slap Full Clinical Hold on CTI BioPharma's Cancer Drug Pacritinib
AbbVie (ABBV)'s Elagolix Successful in Second Phase III Study
Startup Yumanity Closes on $45 Million, With Biogen (BIIB) and Sanofi-Genzyme BioVentures Joining In
Ex-Salix (SLXP) CEO, CFO Investigated for Misleading Investors About Drug Inventory Levels
See All News >
//-->